These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34124016)

  • 21. On-chip construction of a fully structured scaffold-free vascularized renal tubule.
    Zhu Y; Shi Z; Ding W; Li C
    Biomed Microdevices; 2023 Feb; 25(1):8. PubMed ID: 36826720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
    Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diverse Receptor Tyrosine Kinase Phosphorylation in Urine-Derived Tubular Epithelial Cells from Autosomal Dominant Polycystic Kidney Disease Patients.
    Ikeda K; Kusaba T; Tomita A; Watanabe-Uehara N; Ida T; Kitani T; Yamashita N; Uehara M; Matoba S; Yamada T; Tamagaki K
    Nephron; 2020; 144(10):525-536. PubMed ID: 32799196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.
    Woo YM; Bae JB; Oh YH; Lee YG; Lee MJ; Park EY; Choi JK; Lee S; Shin Y; Lyu J; Jung HY; Lee YS; Hwang YH; Kim YJ; Park JH
    Hum Genet; 2014 Mar; 133(3):281-97. PubMed ID: 24129831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.
    Zhou X; Fan LX; Sweeney WE; Denu JM; Avner ED; Li X
    J Clin Invest; 2013 Jul; 123(7):3084-98. PubMed ID: 23778143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations.
    Kataoka H; Fukuoka H; Makabe S; Yoshida R; Teraoka A; Ushio Y; Akihisa T; Manabe S; Sato M; Mitobe M; Tsuchiya K; Nitta K; Mochizuki T
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31948117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.
    Zhang Z; Bai H; Blumenfeld J; Ramnauth AB; Barash I; Prince M; Tan AY; Michaeel A; Liu G; Chicos I; Rennert L; Giannakopoulos S; Larbi K; Hughes S; Salvatore SP; Robinson BD; Kapur S; Rennert H
    J Am Soc Nephrol; 2021 Dec; 32(12):3114-3129. PubMed ID: 34716216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.
    Zhang W; Stephens CJ; Blumenfeld JD; Behzadi AH; Donahue S; Bobb WO; Newhouse JH; Rennert H; Zhao Y; Prince MR
    J Magn Reson Imaging; 2019 Mar; 49(3):894-903. PubMed ID: 30230107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
    Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
    Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1
    Arroyo J; Escobar-Zarate D; Wells HH; Constans MM; Thao K; Smith JM; Sieben CJ; Martell MR; Kline TL; Irazabal MV; Torres VE; Hopp K; Harris PC
    Kidney Int; 2021 Jun; 99(6):1392-1407. PubMed ID: 33705824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequencing of Saudi Arabian patients with ADPKD.
    Al-Muhanna FA; Al-Rubaish AM; Vatte C; Mohiuddin SS; Cyrus C; Ahmad A; Shakil Akhtar M; Albezra MA; Alali RA; Almuhanna AF; Huang K; Wang L; Al-Kuwaiti F; Elsalamouni TSA; Al Hwiesh A; Huang X; Keating B; Li J; Lanktree MB; Al-Ali AK
    Ren Fail; 2019 Nov; 41(1):842-849. PubMed ID: 31488014
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.
    Yanda MK; Liu Q; Cebotaru L
    J Biol Chem; 2018 Jul; 293(29):11513-11526. PubMed ID: 29875161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a Multitubular Perfusable Kidney-on-Chip for the Study of Renal Diseases.
    Lapin B; Myram S; Nguyen ML; Gropplero G; Coscoy S; Descroix S
    Methods Mol Biol; 2023; 2664():85-106. PubMed ID: 37423984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase X (PRKX) can rescue the effects of polycystic kidney disease-1 gene (PKD1) deficiency.
    Li X; Burrow CR; Polgar K; Hyink DP; Gusella GL; Wilson PD
    Biochim Biophys Acta; 2008 Jan; 1782(1):1-9. PubMed ID: 17980165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of ceramide biosynthesis in increased extracellular vesicle release in
    Carotti V; van der Wijst J; Verschuren EHJ; Rutten L; Sommerdijk N; Kaffa C; Sommers V; Rigalli JP; Hoenderop JGJ
    Front Endocrinol (Lausanne); 2022; 13():1005639. PubMed ID: 36299464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
    Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
    Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.